Showing 20 of 47 recruiting trials for “primary-cutaneous-anaplastic-large-cell-lymphoma”
RecruitingNCT06207812 ↗
Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
RecruitingNCT06382844 ↗
Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL
👨⚕️ Julia M Almeida Parra, Prof., Instituto de Investigación Biomédica de Salamanca📍 1 site📅 Started Jan 2024View details ↗
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
👨⚕️ Ryan Wilcox, University of Michigan Rogel Cancer Center📍 1 site📅 Started Dec 2023View details ↗
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
RecruitingNCT05157581 ↗
Extracorporeal Photopheresis in Sezary Syndrome
RecruitingNCT06421571 ↗
The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
👨⚕️ Michel Zwaan, Prof, Princess Maxima Center for Pediatric Oncology in The Netherlands📍 2 sites📅 Started Aug 2022View details ↗
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
👨⚕️ Brandon Imber, MD, Memorial Sloan Kettering Cancer Center📍 3 sites📅 Started Mar 2022View details ↗
Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma
👨⚕️ Daobin Zhou, Department of Hematology, Peking University First Hospital📍 1 site📅 Started Oct 2021View details ↗
StrataCTX® as a Steroid Sparing Device
Photopheresis in Early-stage Mycosis Fungoides
RecruitingNCT04904146 ↗
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →